common side effects of remicade
abdominal pain
pain
chest pain
nausea
other side effects
candidiasis
diarrhea
pruritus
sinusitis
vomiting
comprehensive list of adverse effects
needed effects
infliximab
active ingredient
remicade
unwanted side effects
medical attention
most-common reasons for discontinuation of treatment
infusion-related reactions
dyspnea
flushing
headache
rash
viral infection
influenza
herpes virus infection
bacterial infections
sepsis
cellulitis
abscess
moniliasisuncommon
tuberculosis
fungal infections
candidiasis
vaginitisrare
meningitis
opportunistic infections
invasive fungal infections
pneumocystosis
histoplasmosis
aspergillosis
coccidioidomycosis
cryptococcosis
blastomycosis
bacterial infections
listeriosis
salmonellosis
viral infections
cytomegalovirus
parasitic infections
hepatitis b reactivation
most cases of tuberculosis
months after the start of infliximab therapy
recrudescence of latent disease
miliary tuberculosis
result of tuberculosis reactivation
year-old white male with a history of crohn
disease
infliximab
infections
organ systems
patients
receiving infliximab
combination with immunosuppressive agents
patients with antibodies
infliximab
higher rates of clearance
efficacy
infusion reaction
crohn
patients
ana
infliximab
times as likely
anti-dsdna antibodies
various case reports of non-crohn
crohn
patient
clinical symptoms of a lupus-like syndrome
symptoms
antibodies
infliximab
infection
fijian indian man
undergoing
twenty-eighth week of infliximab therapy for the treatment of psoriasis
psoriatic arthritis
patient
symptoms
treatment with intravenous ciprofloxacin
disseminated cryptococcal infection
year-old male
second infusion of infliximab for rheumatoid arthritis
year-old male developed protothecosis after a stem cell transplantation
infliximab therapy
administered infliximab for graft-versus-host disease
weeks
developed bilateral olecranon bursitis
bullous skin lesions
blood cultures
klebsiella
patient
multiorgan failure
weeks of hospitalization
use of infliximab
role in this case
upper
respiratory tract infection
sinusitis
pharyngitis
cough
bronchitis
lower respiratory tract infection
pneumonia
dyspnea
pulmonary edema
bronchospasm
pleurisy
pleural effusionrare
interstitial lung disease
including
progressive disease
lung fibrosis
pneumonitis
adult respiratory distress syndromefrequency
respiratory insufficiency
pulmonary embolism
shortness of breath
hot flush
flushing
fatigue
fever
chillsuncommon
impaired healing
autoantibody positiverare
granulomatous lesion
complement factor
order
development
delayed severe systemic reactions
researchers
multiple early infusions of infliximab
active ingredient
remicade
retreatment
delayed hypersensitivity reactions during psoriasis studies
weeks
following repeat infusion
clinical trial
crohn
disease patients
retreated following
years without infliximab
patients
experiencing side effects
following readministration
infusion-related side effects
initial infliximab treatment
anaphylactic reaction
lupus-like syndrome
serum sickness
serum
sickness-like reaction rare
anaphylactic shock
vasculitis
sarcoid-like reactionfrequency
facial
hand
lip edema
sore throat
headache
vertigo
dizziness
hypoesthesia
paresthesiauncommon
seizure
neuropathyrare
transverse myelitis
central nervous system
demyelinating disorders
multiple sclerosis-like disease
optic neuritis
peripheral demyelinating disorders
guillain-barre syndrome
chronic inflammatory demyelinating polyneuropathy
multifocal motor neuropathy
rheumatoid vasculitis
systemic vasculitisfrequency
dysesthesia
meningitis
brain infarction
neuritis
peripheral neuropathy
miller fisher syndrome
patient
hypoesthesia in the left leg
hours
first infliximab infusion
patient
dysesthesia in the distribution of the left peroneal nerve
intravenous infliximab infusion
demyelination
postmarketing experience
causal relationship between adverse events
infliximab
neurologic side effects
discontinuation of therapy
crohn
disease
meningitis
infliximab therapy
patient
headache
fever
arthralgia
myalgia
meningismus
receiving
infliximab infusion
cerebrospinal fluid analysis
neutrophilic pleocytosis
elevated protein
other potential causes of meningitis
patient
symptoms
hours of presentation
year history of crohn disease
acute neuropathy with multiple conduction
infliximab therapy
infliximab
mg/kg
infusions in years
therapy
azathioprine
mg per day
years
disease
weeks after the overall fourth dose of infliximab treatment
left radial nerve palsy
slight weakness of left foot flexion
extension
neurologic examination
motor nerve conduction studies
acute neuropathy with multiple conduction blocks
year-old male with rheumatoid arthritis
west nile virus
wnv
infliximab therapy
patient
day history of fever
headache
confusion
agitation
nausea
malaise
myalgias
gait instability
worsening
worsening lower extremity weakness
received infliximab weeks
symptom onset
other medications
amlodipine
mg per day
methotrexate
mg per week
wnf
cerebral spinal fluid
wnv igm antibodies by elisa capture technique
patient
wnf infection
erosive rheumatoid arthritis
neurosarcoidosis
infliximab therapy
infliximab mg/kg
weeks
methotrexate
side effects
years
receiving
infliximab infusion
feeling
low grade fever
headache
weeks
neurological symptoms besides headache
week
headache
weeks after admission
diplopia
neuron-ophthalmological examination
nerve palsy of the left eye
severe papilledema
eyes
bilateral granulomatous iridocyclitis
retinal periphlebitis
sarcoidosis
sarcoidosis diagnosis
increased activity in the mediastinal lymph nodes
parotid glands
in-dtpa-octreotide scintigraphy
ventriculoperitoneal shunt weeks
being
following surgery
patient
headache
pathological ophthalmologic changes
year-old female
days
reaction
shaking
taking infliximab
patient
date of admission
long time
twenties
patient
being
crohn
disease at age
nausea
abdominal pain
diarrhea
dyspepsia
gastrointestinal hemorrhage
gastroesophageal reflux
constipation
vomitinguncommon
intestinal perforation
intestinal stenosis
diverticulitis
pancreatitis
cheilitisfrequency
abdominal hernia
abscess
intestinal obstruction
proctalgia
ileus
abdominal hernia
abscess
intestinal obstruction
peritonitis
proctalgia
tachycardia
palpitation
chest painuncommon
cardiac failure
new onset
worsening
arrhythmia
syncope
bradycardia
peripheral ischemiarare
cyanosis
pericardial effusion
circulatory failure
vasospasmvery
heart blockfrequency
myocardial ischemia/myocardial infarction
hours of infusion
higher incidence of mortality
hospitalization
worsening heart failure
patients with moderate
nyha class iii-iv
heart failure
higher dose of infliximab
mg/kg
year
patients in the infliximab mg/kg group
deaths
infliximab mg/kg
placebo group
heart failure
n =-rrb-
postmarketing experience
average months after initiation of infliximab therapy
bradycardia with second degree atrioventricular
av
block
minutes into the infliximab infusion
year-old woman
fistulizing crohn
disease
previous history of cardiac disease
bradycardia
second degree av block
hours after infliximab
cardiology
placement of a pacemaker
patient
infliximab therapy without adverse events
year-old man
fistulizing crohn
disease
prior history of coronary artery disease
taking atenolol
dyspnea
chest heaviness
dizziness
receiving
third infusion of infliximab
reported chills
pruritus during previous infusions of infliximab
drop in heart rate with ecg
showing type
sinoatrial block
patient
permanent pacemaker
infliximab therapy
patient
surgery
fistulizing crohn
disease
rash
ecchymosis
new onset
worsening psoriasis
pustular psoriasis
palms
soles
urticaria
pruritus
hyperhidrosis
dry skin
fungal dermatitis
alopeciauncommon
bullous eruption
onychomycosis
rosacea
skin papilloma
hyperkeratosis
abnormal skin pigmentation
cellulitis
eczema/seborrhea
furunculosis
verrucarare
petechia
granulomatous lesionvery
toxic epidermal necrolysis
stevens-johnson syndrome
erythema multiforme
necrotising fasciitis
bullous skin lesions
aggressive cutaneous t-cell lymphomaspostmarketing reports
symptoms of dermatomyositis
necrotizing fasciitis
death
year-old man with rheumatoid arthritis
receiving infliximab
weeks
intramuscular methotrexate
weekly dosage
blood cultures
skin swabs
hemolytic group
streptococcus
bullous skin lesions
year-old white man
day
fourth dose of infliximab for the treatment of severe rheumatoid arthritis
proximity of symptoms
infliximab
causality
cases of aggressive cutaneous t-cell lymphomas
therapy with infliximab
sezary syndrome
patient after months of treatment
systemic anaplastic large cell lymphoma with cutaneous involvement
other patient
weeks
third dose of infliximab
crohn disease
acne
infliximab therapy
patient
been administered infliximab mg/kg with rapid
effective symptomatic control
several weeks
initiating infliximab therapy
patient
papulopustular eruption on the face
comedones
eruption
fluctuating severity
dermatological opinion
histology
clinical diagnosis of acne
other crohn
disease-associated dermatoses
infliximab
excellent control of the bowel disease
patient
minocycline mg
year-old male with rheumatoid arthritis
ra
primary cutaneous nocardia otitidiscaviarum infection after a skin injury
infliximab therapy
ra with infliximab
mg/kg
years
methotrexate
mg/week
corticosteroids
weeks before the th infusion of infliximab
deep wound
right palm
hand lesion
erythematous pustular lesion
anterior side
right forearm
weeks
lesion
cutaneous nonpainful ulcer
white pus
erythematous periphery
nocardia otitidiscaviarum
ulcer
biological samples
inflammation
infliximab therapy
combination clindamycin
ofloxacin
antibiotic therapy for months
days
skin ulcer
history of rheumatoid arthritis
ra
atypical varicella exanthema
infliximab therapy
patient
day history of pruritic
pruritic generalized papulovesicles
flaccid vesicles
pustules
erosions
fever
sore throat
ra
methotrexate
mg per week
bucillamine
mg per day
years
medication
ra
infliximab
mg/kg
weekly intervals
days after the second course of infliximab therapy
cutaneous eruption
polymerase chain reaction
varicella zoster virus
findings
patient
varicella
course of intravenous acyclovir
prophylactic antibiotics for days
weeks
recovery
minimal scars
year-old male with a
year history of diffuse polyarthritis
leprosy
type leprosy reaction
infliximab therapy
patient
been given courses of infliximab
been given months
admission
month
first dose of infliximab
patient
rash on extremity
extremities
results of a skin biopsy
leprosy
hansen disease
multidrug therapy
mdt
dapsone
mg
clofazimine
mg
rifampin
mg monthly
month
starting
treatment
patient
reversal
type
reactions
years
cutaneous lesions
mdt
results of a skin biopsy
performed years after diagnosis
advanced regression of the lesion with no residual bacilli
crohn disease
palmoplantar pustulosis
ppp
infliximab therapy
patient
regimen of infliximab of mg/kg
complete remission
bowel symptoms
month
classic ppp
mild psoriasiform eruption on the lower legs
patient
feet
mobility
treatment
prescribed betamethasone dipropionate
polythene occlusion at night
soap-free wash
moisturizer
following
weeks
patient
additional psoriasis therapy
alopecia areata
year-old white woman with rheumatoid arthritis
sjogren syndrome after months of infliximab therapy
hair loss
scalp
eyebrows
eyelashes
lymphoma
lymphoma
hodgkin
disease
leukemia
melanomavery
breast cancer
colorectal cancerfrequency
hepatosplenic t-cell lymphoma
adolescents
young adults with crohn
disease
ulcerative colitis
merkel cell carcinomafrequency
nonmelanoma skin cancer
neoplasms
basal cell
breast
clinical trials of infliximab
fold
higher incidence
general population
developing lymphomas among rheumatoid arthritis patients
patients
crohn
disease
rheumatoid arthritis
higher incidence
general population
patients
active disease
chronic exposure
immunosuppressants
higher risk
several fold
population at large for the development of lymphoma
controlled clinical trial
use of infliximab in patients with moderate
severe copd
current smokers
ex-smokers
patients
malignancy
including lymphoma
acute lymphoblastic leukemia
patient
days
receiving
third infusion of infliximab mg/kg for the treatment of crohn
disease
causal relationship
postmarketing
postmarketing adverse events reports
lymphoproliferative disorders
n =-rrb-
average
weeks after initiation of therapy with infliximab
majority of cases
lymphomas
meta-analysis
dose-dependent increased risk of malignancies in patients with rheumatoid arthritis
anti-tnf antibody therapy
ankylosing spondylitis
sezary syndrome
infliximab therapy
nonsteroidal antiinflammatory drugs
prednisone mg
months
treatment
infliximab mg/kg at monthly intervals
months of this therapy
sezary syndrome
cutaneous lesions
remitted following infliximab discontinuation
methotrexate treatment
hepatic function
transaminases increaseduncommon
hepatitis
hepatocellular damage
cholecystitis
cholelithiasisrare
autoimmune hepatitis
jaundicefrequency
liver failure
autoimmune hepatitis
biliary pain
cytomegalovirus
severe hepatic reactions
weeks
year after initiation of infliximab
patients
elevated alt
ast
abnormalities
continuation
discontinuation of infliximab
modification of concomitant medications
cholestatic liver disease
year-old woman days after a single dose of infliximab
history of crohn disease
cytomegalovirus hepatitis
infliximab therapy
been administered mercaptopurine mg per day for the past years until intravenous infliximab mg/kg
week intervals
better control of the disease
year
patient
hospital with a
week history of daily fever
chills
several courses of empirical antimicrobial therapy
histological examination of a liver biopsy specimen
intranuclear inclusion bodies
cytomegalovirus by paraffin immunoperoxidase staining with antibody against this virus
intravenous ganciclovir mg/kg
daily therapy
patient
symptoms
laboratory values
few days
neutropenia
leucopenia
lymphadenopathyuncommon
thrombocytopenia
lymphopenia
lymphocytosis
thrombophlebitis
hematoma
pyelonephritisrare
agranulocytosis
thrombotic thrombocytopenic purpura
pancytopenia
hemolytic anemia
idiopathic thrombocytopenic purpura
frequency
aplastic anemia
splenic infarction
splenomegaly
cases of leukopenia
neutropenia
thrombocytopenia
pancytopenia
fatal outcome
arthralgia
myalgia
painuncommon
tendon injuryfrequency
intervertebral disk herniation
infective arthritis
swelling of fingers
paresthesia in the forearm region
kidney infarction
renal calculus
renal failurevery
iga nephropathy
pyelonephritis
dehydrationfrequency
extra-high levels of vldl-triglycerides
injection site reaction
erythema
pruritus
rash
pain of mild
moderate severity
urinary tract infection
moniliasisfrequency
menstrual irregularity
herpes simplex
endometritis
dysuria
urethral obstruction
conjunctivitisuncommon
keratitis
periorbital edema
hordeolum rare
endophthalmitisvery
retrobulbar optic neuritis of the left eye
orbital cellulitis
third nerve palsy
transient visual loss
infliximab
active ingredient
remicade
administration
hours of infusion
frequency
transient visual loss
hours of infusion
year-old woman
rheumatoid arthritis
decreased vision in the left eye
pain with eye movement days
infusion
year of treatment
infliximab
patient
vision
visual field deficit
treatment with g methylprednisolone injection per day for days
tapering dose of oral prednisone over days
week after the seventh infusion of infliximab mg/kg
year-old woman with type diabetes mellitus
crohn
disease
pain
vision in the left eye
visual acuity
patient
treatment with intravenous methylprednisolone
tapering dose of oral prednisone
examination months
visual acuity
normal color vision
mild residual left-sided headache
normal-appearing optic nerve in the left eye
year-old male developed severe unilateral orbital cellulitis
receiving infliximab therapy
ankylosing spondylitis during a clinical trial
cultures
infliximab therapy
patient
full recovery
receiving
receiving appropriate antibiotic therapy
infliximab treatment
weeks
year-old male with rheumatoid arthritis
third nerve palsy
infliximab therapy
monthly infusions of mg of infliximab for the disease
painless ptosis
right upper eyelid
double vision in left
brain
magnetic resonance imaging
mri
gadolinium enhancement of the cisternal segment of the right oculomotor nerve
stopping infliximab therapy
diplopia
ptosis
months
repeat mri imaging
resolution of the oculomotor nerve enhancement
depression
insomniauncommon
amnesia
agitation
confusion
somnolence
nervousnessrare
apathyfrequency
suicide attempt
side effects of remicade
fda
healthcare professional for medical advice
stomach pain
chest pain
chills
cough
dizziness
fainting
fever
flushing of the face
headache
hives
itching
rash
muscle pain
nasal congestion
nausea
runny nose
sneezing
sore throat
tightness in the chest
troubled breathing
unusual tiredness
weakness
vomiting
back pain
cloudy urine
cracks in the skin at the corners of the mouth
diarrhea
painful urination
frequent urge
pain
tenderness around the eyes
cheekbones
skin rash
soreness
irritation of the mouth
tongue
soreness
redness around the fingernails
toenails
vaginal burning
itching
discharge
white patches in the mouth
tongue
abscess
area of infection
containing pus
side pain
black, tarry stools
blood in the urine
stools
bone
joint pain
constipation
feeling of fullness
hernia
pounding heartbeat
pain in the rectum
pain spreading from the abdomen
stomach
left shoulder
red spots on the skin
stomach pain (severe)
painful glands
tendon injury
unusual bleeding
bruising
unusual weight loss
yellow skin
eyes
area rash
bloody nose
burning
tingling
numbness
pain in the hands
arms
feet
legs
change in mental status
clay-colored stools
continuing vomiting
convulsions
bloody urine
difficulty with speaking
difficulty with swallowing
fast heartbeat
general feeling of tiredness
weakness
heavier menstrual periods
hoarseness
inability
arms
legs
itching
puffiness
swelling of the eyelids
eyes
face
lips
tongue
light-colored stools
loss of appetite
loss of bladder control
side pain
muscle spasm
jerking of all extremities
noisy breathing
painless swelling in the neck
armpits
groin
pale skin
scaling
crusted skin
redness
soreness
itching skin
seizures
sensation of pins
needles
stomach pain
severe muscle weakness
progressing
irregular breathing
sores
welting
blisters
stabbing pain
sudden loss of consciousness
sudden numbness
weakness in the arms
legs
unpleasant breath odor
upper right stomach pain
vomiting of blood